S 164
Advancing Education on Biosimilars Act of 2021
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the Advancing Education on Biosimilars Act of 2021, directs the Food and Drug Administration (FDA) to increase public and healthcare provider understanding of biosimilars. Specifically, it mandates the creation and maintenance of an FDA website offering educational materials about biological products, including biosimilars and interchangeable biosimilars. The bill also requires the FDA to develop and improve continuing education programs for healthcare professionals to promote the appropriate use of these medications.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.